KP Tissue Inc. (TSE:KPT - Get Free Report)'s stock price hit a new 52-week high on Tuesday . The company traded as high as C$9.66 and last traded at C$9.66, with a volume of 10377 shares trading hands. The stock had previously closed at C$9.60.
Analysts Set New Price Targets
KPT has been the subject of a number of research analyst reports. TD Securities boosted their target price on shares of KP Tissue from C$8.00 to C$9.00 and gave the stock a "hold" rating in a research note on Thursday, May 22nd. National Bankshares boosted their target price on KP Tissue from C$9.50 to C$10.00 and gave the company a "sector perform" rating in a research note on Thursday, August 14th. Finally, Desjardins lifted their price objective on KP Tissue from C$9.50 to C$10.00 and gave the company a "hold" rating in a report on Thursday, August 14th. Three research analysts have rated the stock with a Hold rating, According to data from MarketBeat.com, the company has an average rating of "Hold" and an average price target of C$9.38.
Read Our Latest Stock Analysis on KP Tissue
KP Tissue Stock Performance
The firm has a market capitalization of C$94.84 million, a price-to-earnings ratio of 14.86, a PEG ratio of -0.88 and a beta of 0.37. The company has a fifty day moving average of C$9.19 and a two-hundred day moving average of C$8.56.
KP Tissue Dividend Announcement
The firm also recently disclosed a quarterly dividend, which will be paid on Wednesday, October 15th. Stockholders of record on Tuesday, September 30th will be paid a $0.18 dividend. This represents a $0.72 dividend on an annualized basis and a dividend yield of 7.6%. KP Tissue's dividend payout ratio is 112.73%.
About KP Tissue
(
Get Free Report)
KP Tissue Inc, through its interest in Kruger Products L.P., produces, distributes, markets, and sells a range of disposable tissue products in Canada and the United States. The company operates through two segments, Consumer and Away-From-Home. It offers bathroom and facial tissues, paper towels, and napkins.
Recommended Stories
Before you consider KP Tissue, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and KP Tissue wasn't on the list.
While KP Tissue currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Wondering what the next stocks will be that hit it big, with solid fundamentals? Enter your email address to see which stocks MarketBeat analysts could become the next blockbuster growth stocks.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.